# Trade Mark Journal No.2026/032 7 August 2026

## WO0000001929668 (1,5,40,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:6 May 2026
Date of designation in the UK: 6 May 2026

International priority date claimed: 10 December 2025 (European Union Intellectual Property Office (EUIPO)) (019289552)

Class 1
  Chemicals for use in industry and science; biological preparations for use in industry and science; peptides for industrial purposes; peptide substrates for scientific purposes; amino compounds; amino acids for industrial purposes; preservatives for pharmaceuticals; chemicals for use in manufacturing pharmaceuticals; active chemical ingredients; diagnostics preparations, other than for medical or veterinary use.
Class 5
  Pharmaceuticals; pharmaceutical preparations; medical preparations; veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for veterinary use; dietetic substances adapted for medical use; dietetic substances for babies; dietary supplements; synthetic peptides for pharmaceutical purposes; amino acids for veterinary purposes; amino acids for medical purposes; amino acid preparations for medical purposes; clinical medical reagents; clinical diagnostic reagents.
Class 40
  Custom manufacture of pharmaceuticals; custom biomanufacturing of pharmaceuticals; processing of chemicals; provision of information relating to chemical processing; treatment of chemical and medical waste; custom manufacture of medical devices for others; information in relation to the above services.
Class 42
  Scientific and technological services; scientific and technological design; scientific research; technological research; industrial analysis and research services; chemical analysis; chemical research; chemical engineering; chemical laboratories; pharmaceutical products development; research of pharmaceuticals; testing of pharmaceuticals; development of pharmaceutical preparations and medicines; research relating to medicine; development of gene-based medicines; pharmaceutical product evaluation; clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical research.

Corden Pharma International GmbH

Representative: OFFICE FREYLINGER S.A., 234, route d'Arlon B.P. 48, L-8001 Strassen, LUXEMBOURG